Loading the content... Loading depends on your connection speed!

Enter New Email
Confirm New Email
Enter Old Password
Enter New Password
Confirm New Password
 
Email sent successfully to:
Algorithm Information

Hepatitis C Virus and HIV | Risk Factors for Hepatic Decompensation During Interferon-Ribavirin Therapy

MyLikes

MyPaths
Purpose:
To identify risk factors for hepatic decompensation in a patient coinfected with HIV and HCV who is being treated with interferon-ribavirin.
Specialty
  • Infectious Diseases
    Pharmacology
  • Clinical
Gastroenterology
Objective
  • Risk factors
  • Pharmacogenetics
  • Adverse effects
ICD-10
  • B17.1
  • B18.2

In order to access the algorithms, please subscribe to a plan that fits your needs.

MyPaths
Cancel
Create Path
Create
Cancel
Create Note
Save
Hepatitis C Virus and HIV | Risk Factors for Hepatic Decompensation During Interferon-Ribavirin Therapy
Cancel
Save Data
Save
Limitation to 5 characters is for patient privacy.